Psilo-Balsam® (Gel) Instructions for Use
Marketing Authorization Holder
Nizhpharm JSC (Russia)
Contact Information
NIZHPHARM group of companies (Russia)
ATC Code
D04AA32 (Diphenhydramine)
Active Substance
Diphenhydramine (Rec.INN registered by WHO)
Dosage Form
| Psilo-Balsam® | Gel for external use 1%: 20 g or 50 g tubes |
Dosage Form, Packaging, and Composition
Gel for external use 1% colorless, transparent, homogeneous.
| 1 g | |
| Diphenhydramine hydrochloride | 10 mg |
Excipients : cetylpyridinium chloride – 1 mg, macrogolglycerol caprylocaprate (softigen 767) – 150 mg, polyacrylic acid – 12 mg, trometamol – 22.2 mg, purified water – 804.8 mg.
20 g – aluminum tubes (1) – cardboard packs.
50 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with antiallergic action for external use
Pharmacotherapeutic Group
Antipruritic agents, including antihistamines, anesthetics, and others; antihistamines for topical use
Pharmacological Action
An antiallergic agent, a histamine H1-receptor blocker. It has pronounced antihistamine activity, reduces increased capillary permeability, tissue swelling, and hyperemia. It has a local anesthetic effect.
Diphenhydramine has a pronounced antiallergic effect and quickly reduces itching.
Psilo-Balsam® has a cooling effect. The special gel base protects the skin and does not leave a visible mark.
Pharmacokinetics
Data on the pharmacokinetics of Psilo-Balsam® are not provided.
Indications
- Sunburns and first-degree burns;
- Insect bites;
- Urticaria;
- Skin itching of various origins;
- Pruritic eczema;
- Chickenpox;
- Allergic skin irritations (except for cholestatic pruritus);
- Contact dermatitis caused by contact with plants.
ICD codes
| ICD-10 code | Indication |
| B01 | Varicella [chickenpox] |
| L20.8 | Other atopic dermatitis (neurodermatitis, eczema) |
| L23 | Allergic contact dermatitis |
| L24 | Irritant contact dermatitis |
| L28.0 | Lichen simplex chronicus (circumscribed neurodermatitis) |
| L29 | Pruritus |
| L30.0 | Nummular eczema |
| L50 | Urticaria |
| L55 | Sunburn |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T30 | Burns and corrosions of unspecified body region |
| ICD-11 code | Indication |
| 1E90.Z | Varicella, unspecified |
| 9A06.70 | Atopic eczema of the eyelids |
| EA80.0 | Infantile atopic eczema |
| EA80.1 | Childhood atopic eczema |
| EA80.2 | Adult atopic eczema |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EA83.00 | Lichen simplex of vulva |
| EA83.01 | Lichen simplex of male genital organs |
| EA83.02 | Lichen simplex of perianal area |
| EA83.0Z | Lichen simplex of unspecified location |
| EA85.20 | Atopic hand eczema |
| EC90.Z | Itching, unspecified |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EK00.Z | Allergic contact dermatitis, unspecified |
| EK02.Z | Irritant contact dermatitis, unspecified |
| ND56.0 | Superficial injury of unspecified body region |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply a thin layer of the gel, approximately 2-3 grams, to the affected skin areas.
Administer the gel three to four times daily or as directed by a physician.
Gently rub the preparation into the skin until fully absorbed.
Ensure hands are clean before and after application to prevent secondary infection.
Do not apply to extensive areas of the body, as systemic absorption may lead to adverse effects.
Avoid application to broken skin, deep wounds, or severe burns without medical supervision.
Discontinue use and consult a physician if skin irritation or allergic reactions occur.
The duration of treatment depends on the condition being treated and its severity.
Do not use occlusive dressings over the treated area unless instructed by a healthcare professional.
Adverse Reactions
Allergic reactions skin manifestations are possible.
Contraindications
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
The drug should be used with caution during pregnancy.
Breastfeeding is recommended to be suspended during treatment.
Special Precautions
The drug contains light fatty components; it can be used as a skin cream.
During treatment with Psilo-Balsam®, the patient should avoid sun exposure and alcohol consumption.
Effect on the ability to drive vehicles and operate machinery
During treatment, the patient should exercise caution when engaging in activities requiring increased concentration and speed of psychomotor reactions.
Overdose
Symptoms when applying the drug to large surfaces, intoxication is possible – dry mouth, difficulty breathing, agitation, confusion.
Treatment symptomatic therapy against the background of careful monitoring of respiratory function and blood pressure.
Drug Interactions
Data on the drug interaction of Psilo-Balsam® are not provided.
Storage Conditions
List B. The drug should be stored at a temperature not exceeding 25°C (77°F).
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer